SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-23-000068
Filing Date
2023-02-27
Accepted
2023-02-27 08:01:32
Documents
12
Period of Report
2023-02-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20230224.htm   iXBRL 8-K 49559
  Complete submission text file 0001485003-23-000068.txt   194007

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20230224.xsd EX-101.SCH 1902
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20230224_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20230224_pre.xml EX-101.PRE 13046
6 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20230224_htm.xml XML 11848
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 23670098
SIC: 2834 Pharmaceutical Preparations